The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kim Christopher since 2025.
This trader's CIK number is 2040022.
At the time of last reporting, Kim Christopher was the Chairman and CMO of Apimeds Pharmaceuticals Us, Inc.. (stock ticker symbol APUS).
Also see all insider trading activities at Apimeds Pharmaceuticals Us, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | APUS | 27,500 | $50,358 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-14 | APUS | Buy | 7,730 | 1.86 | 14,377 |
| 2025-05-13 | APUS | Buy | 19,770 | 1.82 | 35,981 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kim Christopher (Chairman and CMO of Apimeds Pharmaceuticals Us, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.